Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2003
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220484 Modified ciliary neurotrophic factors
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220473 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
11/27/2003US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction
11/27/2003US20030220471 Extracellular proteins coded by nucleic acids, receptor or membrane-bound proteins, amino acid sequence lacking the signal peptide; use as drugs as thrombolytic agents, interferons, interleukins, erythropoietins
11/27/2003US20030220405 DNA encoding an epsilon, epsilon-lycopene cyclase from romaine lettuce
11/27/2003US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
11/27/2003US20030220289 Compositions for delivering nucleic acids to cells
11/27/2003US20030220288 Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy
11/27/2003US20030220282 Antisense modulation of PTP1B expression
11/27/2003US20030220280 Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate CNS nerve regeneration
11/27/2003US20030220278 Introducing into the T cell a nucleic acid encoding B- Raf operably linked to a promoter; thereby inducing the T cell to proliferate in response to the antigen.
11/27/2003US20030220261 Administering a gene-regulatory peptide or functional analogue thereof that modulates (especially inhibits) translocation and/or activity of a gene transcription factor such as an NF-kappa B/Rel protein.
11/27/2003US20030220260 Gene-regulatory peptide that modulates translocation or activity of a gene transcription factor, such as an NF-kappaB/Rel protein.
11/27/2003US20030220259 Treatment of neurological disorders
11/27/2003US20030220258 Treatment of ischemic events
11/27/2003US20030220257 Administering a gene-regulatory peptide or functional analogue thereof modulate or treat an immunosuppressive state; modulating activity of a gene transcription factor such as an NF-kappa B/Rel protein.
11/27/2003US20030220256 Truncated 24kDa basic fibroblast growth factor
11/27/2003US20030220244 Contacting a culture of an adult stem cells with a hedgehog polypeptide to promote the growth and differentiation of a three dimensional cartilage matrix in the culture cells, isolating and transplanting the cartilage matrix to a patient
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/27/2003US20030219898 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
11/27/2003US20030219897 A vector for transfecting a plant cell, obtained from a tomato mosaic virus, a tobacco masaic virus, producing an antisense RNA or a suppressor RNA, for inhibiting or reducing of gene expression
11/27/2003US20030219896 Sugar cane production
11/27/2003US20030219894 Induction of insulin-producing cells
11/27/2003US20030219892 Illuminating the cells to obtain an image, determining the locations of specific individual cells, using energy beam to induce a response; detection, for drug delivery of genes into specific cells of interest
11/27/2003US20030219889 A culturing dish having the photosensitive polymer modified by a photochromic dye, having adhesive surface for the growth anchorage-dependent cells, irradiated with light to release the cell at specific position
11/27/2003US20030219888 Binding enzyme, toxin with inorganic catalyst or fusion proteins which are contained in achromobacter cells, for using diagnositic, therapeutic, and drug screening
11/27/2003US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2003US20030219876 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219874 Comprises endothelial differentiation gene receptor proteins (EDG8) for monitoring receptivity to and/or diagnosing cancer, angiogenesis and inflammation
11/27/2003US20030219873 Self-assembling recombinant papillomavirus capsid proteins
11/27/2003US20030219871 Genetically engineered mammalian cell comprising increased viability and antiapotosis activity; animal models; gene therapy
11/27/2003US20030219869 Expression of recombinant human proteins in Tetrahymena
11/27/2003US20030219866 Culturing pluripotent cells and monitoring expression of transcriptional marker protein (OCT4); animal models for cell differentiation; veterinary medicine
11/27/2003US20030219864 Novel variants of RANKL protein
11/27/2003US20030219859 Preparing viral protein 22 (VP22) for use as gene therapeutic tool in treatment of cancer; drug delivery
11/27/2003US20030219856 Comprises nucleotide sequences coding chimeric membrane proteins for diagnosing and treating cancer; antiproliferative/antitumor/antiinflammatory agents
11/27/2003US20030219806 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
11/27/2003US20030219758 Comprises nucleotide sequences for diagnosis, prevention and treatment of metastasis, autoimmune and nervous system disorders
11/27/2003US20030219752 Preparing immunoglobulin library; high throughput assay; immunoassays; immunotherapeutics and/or diagnostics; anticarcinogenic agents
11/27/2003US20030219750 Schizophrenia associated genes, proteins and biallelic markers
11/27/2003US20030219742 Antisense modulation of HMGI-C expression
11/27/2003US20030219741 Novel full-length cDNA
11/27/2003US20030219740 DNA sequences isolated from human colonic epithelial cells
11/27/2003US20030219739 Comprises muscle protein for treating and preventing of muscle atrophy
11/27/2003US20030219735 Genetically engineered adeno-associated viral vector comprising single stranded heterologous nucleotide sequence for use as tool diagnostic tool in gene therapy and genomic screening
11/27/2003US20030219724 Identifying signal sequences which facilitate the transfer of active agents through human and animal tissues; drug delivery
11/27/2003US20030219714 Apparatus for identifying and characterizing toxic compounds; drug screening; side effect reduction
11/27/2003US20030219712 Addition of glycolysis inhibitor to a pathogen reduction and storage solution
11/27/2003US20030219463 Comprises cytotoxic lymphocytes which express CD3-antigen; cytokines
11/27/2003US20030219460 Cotton rat lung cells for virus culture
11/27/2003US20030219442 Human monoclonal antibodies to influenza M2 protein and methods of making and using same
11/27/2003US20030219438 Human antibodies that bind human TNFalpha
11/27/2003US20030219428 Deoxyribonuclease formed by genetic engineering, used for prophylaxis respiratory system disorders, lupus erythematosus and/or genetic disorders
11/27/2003US20030219426 Endostatins used as antiproliferative agents or angiogenesis inhibitors for prophylaxis of tumors, or as contraceptives
11/27/2003US20030219425 Modulation of graft versus host disease by providing the organs with gene regulatory peptides, which control translocation and/or transcription factors; immunology
11/27/2003US20030219424 Polynucleotide codes for amino acid sequences used for medical diagnosis, prophylaxis autoimmune diseases, as antiallergens or antitumor agents
11/27/2003US20030219423 Methods of inducing or enhancing connective tissue repair
11/27/2003US20030219421 Genetic vectors comprising polynucleotide codes for vitamin D-dependent calcium binding protein, administered for prevention of apoptosis in cells and prophylaxis of osteoporosis
11/27/2003US20030219420 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/27/2003US20030219419 Alteration of cell membrane for new functions
11/27/2003US20030219418 Diabetic treatment by regenerating pancreas cells, genetic engineered animal embryonic pancreatic cells from different species, inserting embryonic cells into the kidney capsule of non-obese diabetic/ severe combined immunodeficiency animal
11/27/2003US20030219416 Cloning human epithelial tissue
11/27/2003US20030219415 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
11/27/2003US20030219413 Method for overexpression of zwitterionic polysaccharides
11/27/2003US20030219411 Modulators of the function of FAS receptors and other proteins
11/27/2003US20030219408 Methods of making pharmaceutical compositions with minicells
11/27/2003US20030219385 Contrast agents for magnetic resonance imaging and methods related thereto
11/27/2003CA2812019A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2752143A1 Delivery of nucleic acid-like compounds
11/27/2003CA2486583A1 Marker molecules associated with lung tumors
11/27/2003CA2486529A1 Novel phospholipases and uses thereof
11/27/2003CA2485969A1 Carotene synthase gene and uses therefor
11/27/2003CA2485463A1 A direct cellular energy delivery system
11/27/2003CA2484655A1 Transgenic ungulates capable of human antibody production
11/27/2003CA2483692A1 Constitutively translocating cell line
11/27/2003CA2481799A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2481783A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/26/2003EP1365032A1 Marker molecules associated with lung tumors
11/26/2003EP1365026A1 Dna encoding l-ribose isomerae and use thereof
11/26/2003EP1365018A1 CD100 semaphorin in myelination
11/26/2003EP1365017A1 Cell-culturing device and sorting method using same
11/26/2003EP1364969A2 Human tissue factor related DNA segments, polypeptides and antibodies
11/26/2003EP1364963A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof
11/26/2003EP1364197A2 High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation
11/26/2003EP1364056A2 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits
11/26/2003EP1364055A2 Solubility reporter gene constructs
11/26/2003EP1364038A2 Adenovirus particles with mutagenized fiber proteins
11/26/2003EP1364031A1 Hiv-like particles and the use thereof
11/26/2003EP1364024A2 Endogenous and non-endogenous versions of human g protein-coupled receptors
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1364021A2 Compositions and methods relating to colon specific genes and proteins
11/26/2003EP1364018A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
11/26/2003EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/26/2003EP1364007A1 Circular extra-chromosomal dna elements
11/26/2003EP1364006A2 Methods to identify mutant cells with altered sialic acid
1 ... 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 ... 1827